Arrowhead Pharmaceuticals, Inc. (ARWR): Price and Financial Metrics

Arrowhead Pharmaceuticals, Inc. (ARWR): $63.42

-0.09 (-0.14%)

POWR Rating

Component Grades













Add ARWR to Watchlist
Sign Up

Industry: Biotech


of 506

in industry


  • Growth is the dimension where ARWR ranks best; there it ranks ahead of 80.52% of US stocks.
  • ARWR's strongest trending metric is Growth; it's been moving up over the last 47 weeks.
  • ARWR's current lowest rank is in the Momentum metric (where it is better than 7.03% of US stocks).

ARWR Stock Summary

  • Of note is the ratio of Arrowhead Pharmaceuticals Inc's sales and general administrative expense to its total operating expenses; just 11.6% of US stocks have a lower such ratio.
  • With a price/sales ratio of 62.38, Arrowhead Pharmaceuticals Inc has a higher such ratio than 95.75% of stocks in our set.
  • Over the past twelve months, ARWR has reported earnings growth of 290.23%, putting it ahead of 91.83% of US stocks in our set.
  • If you're looking for stocks that are quantitatively similar to Arrowhead Pharmaceuticals Inc, a group of peers worth examining would be ALLO, ARVN, FATE, IMTX, and CUE.
  • ARWR's SEC filings can be seen here. And to visit Arrowhead Pharmaceuticals Inc's official web site, go to

ARWR Valuation Summary

  • ARWR's price/earnings ratio is -55.6; this is 252.33% lower than that of the median Healthcare stock.
  • ARWR's price/sales ratio has moved NA NA over the prior 209 months.
  • Over the past 209 months, ARWR's EV/EBIT ratio has gone NA NA.

Below are key valuation metrics over time for ARWR.

Stock Date P/S P/B P/E EV/EBIT
ARWR 2021-08-31 65.0 16.0 -55.6 -51.4
ARWR 2021-08-30 64.7 16.0 -55.3 -51.1
ARWR 2021-08-27 64.0 15.8 -54.7 -50.5
ARWR 2021-08-26 62.1 15.3 -53.1 -49.0
ARWR 2021-08-25 62.1 15.3 -53.1 -49.0
ARWR 2021-08-24 61.0 15.0 -52.1 -48.0

ARWR Growth Metrics

  • Its 5 year cash and equivalents growth rate is now at 216.02%.
  • Its 5 year net income to common stockholders growth rate is now at 110.37%.
  • The 4 year price growth rate now stands at 514.16%.
ARWR's revenue has moved up $107,255,855 over the prior 70 months.

The table below shows ARWR's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-06-30 107.6379 184.491 -125.9067
2021-03-31 89.12263 180.6738 -109.5939
2020-12-31 79.84049 -110.7831 -102.6115
2020-09-30 87.99207 -95.39157 -84.55323
2020-06-30 123.652 -70.73164 -24.41561
2020-03-31 138.9728 -26.77773 9.531315

ARWR's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • ARWR has a Quality Grade of C, ranking ahead of 55.58% of graded US stocks.
  • ARWR's asset turnover comes in at 0.171 -- ranking 212th of 677 Pharmaceutical Products stocks.
  • CRBP, ASRT, and VBIV are the stocks whose asset turnover ratios are most correlated with ARWR.

The table below shows ARWR's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.171 1 -0.460
2021-03-31 0.153 1 -0.385
2020-12-31 0.149 1 -0.363
2020-09-30 0.158 1 -0.397
2020-06-30 0.241 1 -0.218
2020-03-31 0.303 1 0.013

ARWR Price Target

For more insight on analysts targets of ARWR, see our ARWR price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $87.92 Average Broker Recommendation 1.59 (Moderate Buy)

ARWR Stock Price Chart Interactive Chart >

Price chart for ARWR

ARWR Price/Volume Stats

Current price $63.42 52-week high $93.66
Prev. close $63.51 52-week low $41.26
Day low $62.29 Volume 199,999
Day high $63.70 Avg. volume 781,565
50-day MA $64.74 Dividend yield N/A
200-day MA $72.89 Market Cap 6.61B

Arrowhead Pharmaceuticals, Inc. (ARWR) Company Bio

Arrowhead Pharmaceuticals is a biopharmaceutical company developing targeted RNAi therapeutics. The company was founded in 1989 and is based in Pasadena, California.

ARWR Latest News Stream

Event/Time News Detail
Loading, please wait...

ARWR Latest Social Stream

Loading social stream, please wait...

View Full ARWR Social Stream

Latest ARWR News From Around the Web

Below are the latest news stories about Arrowhead Pharmaceuticals Inc that investors may wish to consider to help them evaluate ARWR as an investment opportunity.

Despite shrinking by US$371m in the past week, Arrowhead Pharmaceuticals (NASDAQ:ARWR) shareholders are still up 804% over 5 years

It hasn't been the best quarter for Arrowhead Pharmaceuticals, Inc. ( NASDAQ:ARWR ) shareholders, since the share price...

Yahoo | September 13, 2021

Arrowhead Pharmaceuticals to Participate in Upcoming September 2021 Conferences

PASADENA, Calif., September 01, 2021--Arrowhead Pharmaceuticals to Participate in Upcoming September 2021 Conferences

Yahoo | September 1, 2021

Is Arrowhead Pharmaceuticals (ARWR) A Good Stock To Buy Now?

No summary available.

Insider Monkey | August 27, 2021

ARWR: New Program Targeting Complement C3 Highlights Expanding Pipeline…

By David Bautz, PhD NASDAQ:ARWR READ THE FULL ARWR RESEARCH REPORT Business Update Pipeline Expansion Continues Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR) is developing medicines that cause gene silencing using RNA interference (RNAi), a specific means of inhibiting the expression of genes and stopping the production of a specific protein. The company has a deep and diverse pipeline consisting

Yahoo | August 10, 2021

Arrowhead Pharmaceuticals, inc (ARWR) Q3 2021 Earnings Call Transcript

ARWR earnings call for the period ending June 30, 2021.

Yahoo | August 6, 2021

Read More 'ARWR' Stories Here

ARWR Price Returns

1-mo 4.53%
3-mo -25.95%
6-mo -5.91%
1-year 33.71%
3-year 248.27%
5-year 795.76%
YTD -17.35%
2020 20.97%
2019 410.71%
2018 237.50%
2017 137.42%
2016 -74.80%

Continue Researching ARWR

Here are a few links from around the web to help you further your research on Arrowhead Pharmaceuticals Inc's stock as an investment opportunity:

Arrowhead Pharmaceuticals Inc (ARWR) Stock Price | Nasdaq
Arrowhead Pharmaceuticals Inc (ARWR) Stock Quote, History and News - Yahoo Finance
Arrowhead Pharmaceuticals Inc (ARWR) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.9857 seconds.